Issued Patents All Time
Showing 25 most recent of 52 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12391933 | Targeted gene insertion for improved immune cells therapy | Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton | 2025-08-19 |
| 12365733 | Method for improving production of car T cells | Alex BOYNE, Laurent POIROT, Alexandre Juillerat | 2025-07-22 |
| 12252699 | Method for generating t-cells compatible for allogenic transplantation | Laurent POIROT, David Sourdive, Jean-Pierre Cabaniols | 2025-03-18 |
| 12221478 | Targeted gene integration of CRS inhibitor genes for improved immune cells therapy | Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton, Mohit Sachdeva | 2025-02-11 |
| 12209125 | Targeted gene integration of NK inhibitors genes for improved immune cells therapy | Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton | 2025-01-28 |
| 12144825 | Cellular immunotherapy for repetitive administration | David Sourdive, Aymeric Duclert, Mathieu SIMON, Alan Marc WILLIAMS, Laurent POIROT | 2024-11-19 |
| 11959091 | Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system | Andre Choulika, Laurent POIROT | 2024-04-16 |
| 11944643 | Universal anti-CD22 chimeric antigen receptor engineered immune cells | Julianne Smith, Murielle Derrien | 2024-04-02 |
| 11912776 | Chimeric antigen receptors targeting B-cell maturation antigen | Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Roman Galetto, Alexandre Juillerat +6 more | 2024-02-27 |
| 11903968 | Engineered immune cells resistant to tumor microenvironment | Anne-Sophie GAUTRON, Laurent POIROT, Julien Valton | 2024-02-20 |
| 11873511 | Targeted gene insertion for improved immune cells therapy | Brian BUSSER, Alexandre Juillerat, Laurent POIROT, Julien Valton | 2024-01-16 |
| 11820996 | Method for generating T-cells compatible for allogenic transplantation | Laurent POIROT, David Sourdive, Jean-Pierre Cabaniols | 2023-11-21 |
| 11778993 | Repeat variable diresidues for targeting nucleotides | Alexandre Juillerat, Claudia Bertonati | 2023-10-10 |
| 11767512 | Sequence specific reagents targeting CCR5 in primary hematopoietic cells | Toni CATHOMEN, Tatjana Cornu, Claudio MUSSOLINO, Marianna ROMITO, Agnes Gouble | 2023-09-26 |
| 11692169 | Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells | Laurent POIROT | 2023-07-04 |
| 11690873 | Universal chimeric antigen receptor T cells specific for CD22 | Cécile SCHIFFER-MANNIOUI, Anne-Sophie GAUTRON | 2023-07-04 |
| 11685935 | Compact scaffold of Cas9 in the type II CRISPR system | Claudia Bertonati | 2023-06-27 |
| 11674155 | Sequential gene editing in primary immune cells | Jean-Pierre Cabaniols, Jean-Charles Epinat | 2023-06-13 |
| 11466291 | Sequential gene editing in primary immune cells | Jean-Pierre Cabaniols, Jean-Charles Epinat | 2022-10-11 |
| 11365430 | Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system | Andre Choulika, Laurent POIROT | 2022-06-21 |
| 11312782 | Chimeric antigen receptors targeting B-cell maturation antigen | Tracy Chia-Chien KUO, Bijan Andre Boldajipour, Javier Fernando Chaparro Riggers, Roman Galetto, Alexandre Juillerat +6 more | 2022-04-26 |
| 11220683 | Method to overcome DNA chemical modifications sensitivity of engineered TALE DNA binding domains | Julien Valton | 2022-01-11 |
| 11198856 | Method for the generation of compact tale-nucleases and uses thereof | Julien Valton, Claudia Bertonati, Jean-Charles Epinat, George H. Silva, Alexandre Juillerat +1 more | 2021-12-14 |
| 11186824 | Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients | Jean-Pierre Cabaniols, Julien Valton, Laurent POIROT | 2021-11-30 |
| 11136566 | Tale-protein scaffolds and uses thereof | Alexandre Juillerat, Julien Valton, Claudia Bertonati, Jean-Charles Epinat, George H. Silva | 2021-10-05 |